T 0559/19 (Single dose oritavancin/MELINTA) of 06.06.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T055919.20230606
- Date of decision
- 6 June 2023
- Case number
- T 0559/19
- Petition for review of
- -
- Application number
- 09810708.9
- IPC class
- A61P 17/00A61K 38/14A61P 31/04
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Methods of treatment using single doses of oritavancin
- Applicant name
- Melinta Therapeutics, Inc.
- Opponent name
- Prüfer & Partner mbB
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 013(2)Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Inventive step - (no)
Late-filed evidence - could have been filed in first instance proceedings (yes)
Amendment after summons - taken into account (no) - Catchword
- -
- Cited cases
- T 0715/03
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.